Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Alteplase

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 177799-16-5, Ttpa, 9,10-bis[n,n-di(p-tolyl)amino]anthracene, 9-n,9-n,10-n,10-n-tetrakis(4-methylphenyl)anthracene-9,10-diamine, N9,n9,n10,n10-tetra-p-tolylanthracene-9,10-diamine, Schembl1261345
    Molecular Formula
    C42H36N2
    Molecular Weight
    568.7  g/mol
    InChI Key
    FWXNJWAXBVMBGL-UHFFFAOYSA-N
    A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    9-N,9-N,10-N,10-N-tetrakis(4-methylphenyl)anthracene-9,10-diamine
    2.1.2 InChI
    InChI=1S/C42H36N2/c1-29-13-21-33(22-14-29)43(34-23-15-30(2)16-24-34)41-37-9-5-7-11-39(37)42(40-12-8-6-10-38(40)41)44(35-25-17-31(3)18-26-35)36-27-19-32(4)20-28-36/h5-28H,1-4H3
    2.1.3 InChI Key
    FWXNJWAXBVMBGL-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC1=CC=C(C=C1)N(C2=CC=C(C=C2)C)C3=C4C=CC=CC4=C(C5=CC=CC=C53)N(C6=CC=C(C=C6)C)C7=CC=C(C=C7)C
    2.2 Synonyms
    2.2.1 MeSH Synonyms

    1. Actilyse

    2. Activase

    3. Alteplase

    4. Lysatec Rt Pa

    5. Lysatec Rt-pa

    6. Lysatec Rtpa

    7. Plasminogen Activator, Tissue

    8. Plasminogen Activator, Tissue Type

    9. Plasminogen Activator, Tissue-type

    10. T Plasminogen Activator

    11. T-plasminogen Activator

    12. Tisokinase

    13. Tissue Activator D 44

    14. Tissue Activator D-44

    15. Tissue Plasminogen Activator

    16. Tissue Type Plasminogen Activator

    17. Tissue-type Plasminogen Activator

    18. Ttpa

    2.2.2 Depositor-Supplied Synonyms

    1. 177799-16-5

    2. Ttpa

    3. 9,10-bis[n,n-di(p-tolyl)amino]anthracene

    4. 9-n,9-n,10-n,10-n-tetrakis(4-methylphenyl)anthracene-9,10-diamine

    5. N9,n9,n10,n10-tetra-p-tolylanthracene-9,10-diamine

    6. Schembl1261345

    7. Dtxsid30629288

    8. Cha79916

    9. 9,10-anthracenediamine, N9,n9,n10,n10-tetrakis(4-methylphenyl)-

    10. Mfcd12022465

    11. Akos027252460

    12. As-71559

    13. 9,10-bis[n,n-di(p-tolyl)amino]anthracene, 98%

    14. N,n,n',n'-tetrakis(p-tolyl)anthracene-9,10-diamine

    15. N,n,n',n'-tetrakis(4-methylphenyl)-9,10-anthracenediamine

    16. N~9~,n~9~,n~10~,n~10~-tetrakis(4-methylphenyl)anthracene-9,10-diamine

    17. N9,n9,n10,n10-tetrakis(4-methylphenyl)anthracene-9,10-diamine

    2.3 Create Date
    2007-12-05
    3 Chemical and Physical Properties
    Molecular Weight 568.7 g/mol
    Molecular Formula C42H36N2
    XLogP312.4
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count2
    Rotatable Bond Count6
    Exact Mass568.287849157 g/mol
    Monoisotopic Mass568.287849157 g/mol
    Topological Polar Surface Area6.5 Ų
    Heavy Atom Count44
    Formal Charge0
    Complexity728
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Fibrinolytic Agents

    Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)